ETF Managers Group, LLC Sorrento Therapeutics, Inc. Transaction History

ETF Managers Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 23, 2023	SELL	$0.74 - $1.83 $11,197 - $27,691	-15,132 Reduced 11.4%	117,646 $104,000
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $14,942 - $28,500	9,896 Added 8.05%	132,778 $208,000
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $34,056 - $63,993	27,465 Added 28.78%	122,882 $245,000
Q1 2022 May 13, 2022	BUY	$2.0 - $4.9 $4,782 - $11,715	2,391 Added 2.57%	95,417 $226,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $432,570 - $672,577	93,026 New	93,026 $456,000
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $6,934 - $10,920	-1,092 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.03 - $16.51 $810,762 - $1.9 Million	-115,329 Reduced 99.06%	1,092 $9,000
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $143,331 - $297,363	24,884 Added 27.18%	116,421 $842,000
Q3 2020 Nov 16, 2020	BUY	$6.17 - $18.82 $148,073 - $451,661	23,999 Added 35.53%	91,537 $1.06 Million
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $116,840 - $456,556	67,538 New	67,538 $413,000

5.53M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.